Combined treatment of primary vitreoretinal lymphomas significantly prolongs the time to first relapse

Abstract

Combined treatment of primary vitreoretinal lymphoma significantly delays the relapse of lymphoma compared with local therapy alone. Intraocular involvement brings significant positive prognostic value when overall survival is compared.